Correvio Pharma Corporation

06/24/2019 | Press release | Distributed by Public on 06/25/2019 16:44

Correvio Resubmits BRINAVESS (vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation